1.Advance in pancreatic duct calculi
International Journal of Surgery 2009;36(9):620-623
The morbidity of pancreatic duct calculus is increasing every year in China. Currently the main therapeutic methods include non-surgical treatment and surgical treatment. Non-surgical treatments contain endoscopic calculus extracting and / or extracorporeal shock wave lithotripsy. Surgical treatment has two categories: drainage of the pancreatic duct decompression and pancreatectomy. Concrete treatment or surgical options should follow the strategy of individual.
2.Advances in the research of neurolytic celiac plexus block
Chinese Journal of Clinical Oncology 2013;(24):1492-1494
Neurolytic celiac plexus block (NCPB) is an effective method used to alleviate upper abdominal pain or back pain caused by pancreatic cancer and other malignancies. NCPB can relieve cancer pain to improve the quality of life and cause fewer side effects than conventional analgesic drugs. This article systemically reviewed NCPB methodology and research progress in clinical appli-cations.
3.Quality check of blood-pressure meter and troubleshooting
Chinese Medical Equipment Journal 1989;0(04):-
This paper expounds the relation between the quality of the blood-pressure meter and the quality of the medical treatment.The good quality of the blood-pressure meter is the basic quality insurance for the medical treatment system.This paper also introduces the method of quality check for the blood-pressure meter and the troubleshooting.
4.Analysis of clinical characteristics of 310 patients with moderate to severe cancer pain
Chinese Journal of Clinical Oncology 2014;(15):989-992
To study the general characteristics of cancer pain and to improve cancer pain diagnosis and treatment lev-el by prospective and open cross-sectional assessment of the clinical characteristics of patients with moderate to severe cancer pain. Methods:Patients with moderate to severe cancer pain were observed upon initial admission to the hospital from December 2012 to De-cember 2013. We assessed pain intensity, location, characteristics, and predisposing and mitigating factors and classified the pain by pathophysiology. Results:A total of 310 patients with moderate (101 cases, 32.58%) and severe (209 cases, 67.42%) pains were as-sessed. The top five cancers identified were lung cancer (102 cases, 32.90%), colorectal cancer (30 cases, 9.68%), pancreatic cancer (27 cases, 8.71%), breast cancer (24 cases, 7.74%), and gastric cancer (20 cases, 6.54%). These patients reported 533 cancer pain locations, including waist (132 cases), abdominal (125 cases), chest (88 cases), lower limb (71 cases), shoulder, neck, and upper limb (47 cases), pelvis (33 cases), perineal area (23 cases), and head and face (14 cases). The pain location of the pancreatic cancer was 90.63%consis-tent with the primary tumor site. The pathophysiology of the pain was classified as follows:bone pain (145 cases, 27.20%), visceral pain (138 cases, 25.89%), soft tissue pain (126 cases, 23.64%), and neuropathic pain (124 cases, 23.27%). The incidence of visceral pain in pancreatic cancer was 92.59%. Conclusion:A variety of common malignancies could cause moderate to severe pain, especially lung cancer. The clinical manifestation of pancreatic cancer pain is visceral pain. The location of this cancer was consistent with the pri-mary tumor site. No apparent specificity was observed in other cancer types.
5.A Contrast Study of the Clinical Effect of Gegensu Injection and Chinese Traditional Medicine on Chronic Renal Failure
Journal of Medical Research 2006;0(08):-
Objective To compare the effect of Gegensu Injection and Chinese Traditional Medicine on Chronic Renal Failure.Methods 70 cases of Chronic Renal Failure were selected as group A, treated by Gegensu Injection; During the same term,60 cases of Chronic Renal Failure were selected as group B, treated by Chinese Traditional Medicine and Chinese Traditional Medicine Clyster. The effect of two methods were valued by analyzing the numeral value of Scr and BUN in two groups . Results 1.Significant effective rate is 8.57, effective rate 41.42, ineffective rate 50, total effective rate 50 in group A; 23.33, 41.67, 35, 65 in group B. 2. After treatment, the numeral value of Scr and BUN in group A had significant difference (P
6.Dissolution Determination of Erythromycin Ethylsuccinate Granules
China Pharmacy 2007;0(25):-
OBJECTIVE:To establish a method for dissolution determination of Erythromycin ethylsuccinate granules.METHODS:Paddle method was adopted and 0.1 mol?L-1 HCl solution was used as dissolution medium at rotation rate of 50 r?min-1.UV spectrophotometry was used to detect at wavelength of 482 nm.Dissolution rate was calculated.RESULTS:The linear range of erythromycin ethylsuccinate were 4~40 mg?L-1(r=0.999 0,n=5)with an average recovery of 99.19%(RSD=0.56%).Dissolution rate of erythromycin ethylsuccinate was more than 80% within 30 min.CONCLUSION:The method is rapid,simple and accurate for the quality control of Erythromycin ethylsuccinate granules.
7.Adenosine promotes bFGF protein and bFGF mRNA expression in human umbilical vein endothelial cells in vitro
Chinese Journal of Pathophysiology 1989;0(05):-
AIM: To investigate the influence of adenosine on human umbilical vein endothelial cells (HUVEC) bFGF protein production and bFGF mRNA expression. METHODS: Immunohistochemistry staining was performed to detect bFGF protein. RT-PCR was performed to detect bFGF mRNA expression. RESULTS: Immunohistochemistry study demonstrated that there was only a small amount of bFGF positive cells and the color was weak in control group (without adenosine). In groups treated with 10~-4 mol/L and 10~-6 mol/L adenosine, bFGF protein was significantly higher than that in control group (P0.05). RT-PCR showed that in 10~-4 mol/L and 10~-6 mol/L adenosine groups, bFGF mRNA expression was higher than that in control group (P0.05). CONCLUSION: Adenosine may promote HUVEC proliferation and angiogenesis partly through inducing bFGF expression.
8.Effect of microecologic modulator combined with antibiotic in treatment of infantile diarrhea
Chinese Journal of Primary Medicine and Pharmacy 2016;23(17):2633-2636
Objective To study the effect of microecologic modulator combined with antibiotic in treatment of infantile diarrhea.Methods 150 children with diarrhea in our hospital were selected as the research subjects,they were randomly divided into observation group and control group,75 cases in each group.The observation group used tyrosine aureus triple viable bacterial combined with amoxicillin therapy,the control group received lactasinum biofermin, vitamin for oral treatment.The curative effect,clinical symptoms and inflammatory factors TNF -ɑ,IL -6,IL -10 changes after treatment for 2 months were compared in the two groups.Results The vomiting,fever,abdominal pain relief time and length of hospital stay in the observation group were (5.12 ±0.52)d,(1.52 ±0.33)d,(1.32 ± 0.41)d,(4.73 ±0.55)d,(5.95 ±0.52)d respectively,which of the control group were (10.33 ±0.64)d,(2.62 ± 0.47)d,(2.21 ±0.32)d,(10.06 ±1.67)d,(11.05 ±1.42)d respectively,which of the observation group were significantly shorter than the control group.The effective rate of the observation group was 97.33% (73 /75),which of the control group was 84.00% (63 /75),the difference between the two groups was statistically significant(χ2 =8.324,P <0.05).Before treatment,the TNF -ɑ,IL -6,IL -10 levels had no obvious differences between the two groups,after treatment,those in the observation group were (2.08 ±0.24)ng/mL,(94.67 ±10.75)ng/mL,(7.58 ± 0.88)ng/mL respectively,those in the control group were (2.88 ±0.37)ng/mL,(128.55 ±17.53)ng/mL,(40.55 ± 1.12)ng/mL respectively,and the levels of the observation group were better than the control group,the differences were statistically significant (t =6.327,5.694,4.156,all P <0.05 ).Conclusion Microecologic modulator combined with antibiotic in treatment of infantile diarrhea can significantly shorten the recovery time of clinical symptoms,reduce inflammation,improve the treatment effect,it is worthy of clinical popularization and application.
9.Research progress on treatment of myelodysplastic syndromes with demethylating drugs
Chinese Journal of Clinical Oncology 2015;(18):895-899
Abnormal epigenetics play important roles in the pathogenesis of myelodysplastic syndromes (MDS). DNA hypermeth-ylation is the most common epigenetic abnormality in MDS. Demethylating DNA hypermethylation may improve the quality of life of MDS patients and prolong their overall survival. Azacitidine and decitabine are the demethylating drugs approved for MDS treatment. These drugs showed clinical effects on all subgroups of MDS patients.
10.Progress on application of adjuvant analgesics in cancer pain man-agement
Chinese Journal of Clinical Oncology 2015;(10):530-534
Adjuvant analgesics refer to a group of drugs that are used not only to treat certain diseases but also to induce analge-sia. Such drugs demonstrate different mechanisms based on the complexity of cancer pain. Thus, opioids, nonsteroidal drugs, and adju-vant analgesics are often combined to control cancer pain. According to the WHO three-step analgesic ladder, adjuvant analgesics can be used at any cancer stage, and the usage of these drugs combined with opioids can reduce the required dosages of these pain relievers, thereby alleviating the adverse reactions associated with opioid use. Moreover, these drugs are particularly suitable for neuropathic pain patients who are not fully sensitive to opioids. The commonly used adjuvant analgesics include antidepressants, anticonvulsants, local administration drugs, corticosteroids, and N-methyl-D-aspartate (NMDA) receptor antagonists. Various adjuvant analgesics also differ in usage and dosage based on primary disease treatment. Therefore, clinical doctors should determine the adverse reactions, proper dos-age, and subsequent amount of dosage to be added in a few days or weeks to achieve balance between the desired effect and adverse re-actions.